Rv0945 Oxidoreductase, short-chain dehydrogenase/reductase family (EC 1.1.1.-)

Summary

Product Feature Type Start End Strand Length AA Length is TF
Rv0945 Oxidoreductase, short-chain dehydrogenase/reductase family (EC 1.1.1.-) CDS 1054247 1055008 + 762 253 FALSE

Rv0945 (Oxidoreductase, short-chain dehydrogenase/reductase family (EC 1.1.1.-)) is predicted to be co-regulated in modules bicluster_0145 with residual 0.56 and bicluster_0226 with residual 0.52.

This regulation is possibly mediated by two de-novo identified cis-regulatory motifs in each module with e-values , 0.00 and 0.16 for bicluster_0145 and 0.00 and 2,000.00 for bicluster_0226 respectively.

These modules are enriched for following go terms: riboflavin metabolic process, riboflavin biosynthetic process, flavin-containing compound metabolic pro..., flavin-containing compound biosynthetic ... .

This gene is found to be for growth on cholesterol.

Mutant available?:

Product (LegacyBRC) Product (RefSeq)
Uncharacterized oxidoreductase Rv0945_MT0971 short chain dehydrogenase
Operon # Operon
630 -
Locus Tuberculist Genome View

Tuberculist

Quickview
Locus Tag KEGG Pathways

KEGG

not assigned to any KEGG Pathway.
BioCyc Gene Page Cellular Overview Map
Link to STRING STRING Network

STRING

GI Number Protein ID Blast Conserved Domains
15608085 NP_215460.1 Run
No TFOE experiment results were found

Quantitative Proteomics Data

t-test p-value Cholesterol/Glycerol Ratio
0.130000 0.11

How essentiality calculations were done?

The relative representation of each mutant was determined by calculating the fold change (sequence reads/insertion in cholesterol divided by sequence reads/insertion in glycerol) for each gene. Statistical significance was determined by t-test. Each insertion site in each replicate sample was treated as a separate data point. The hyperbola used for defining genes specifically required for growth in cholesterol was defined by the formula, y = 3.8/x+0.7. Genes above this line are annotated as required for growth on cholesterol.

TRIP log2 fold abundance change

reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.

p-value Untreated:
p-value INH: